NOBEL BIOCARE DANMARK A/S: Financial statements 2025
CVR: 28293364
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
NOBEL BIOCARE DANMARK A/S (CVR 28293364) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 4,044,322 and a net result of DKK -4,810,707 compared with DKK -4,496,854 the year before. That is an increase of 7.2% compared with the year before. Equity in the 2025 report amounted to DKK -10,951,798. The company had 3 employees in the financial year.
- Gross Profit
- DKK 4,044,322
- Profit/Loss
- DKK -4,810,707
- Equity
- DKK -10,951,798
- Total Assets
- DKK 113,904,387
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 4M | -4.8M | -11M | 3 |
| 2024 | - | 3.8M | -4.5M | -6.1M | 3 |
| 2023 | - | 3.1M | -2M | -1.6M | 4 |
| 2022 | - | 3.3M | -489K | 369K | 3 |
| 2021 | - | 4.3M | 268K | 858K | 3 |
Official annual report
How creditworthy is NOBEL BIOCARE DANMARK A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of August 15, 2025, Jan Jerne has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of August 15, 2025, Jan Jerne is registered as adm. dir. of NOBEL BIOCARE DANMARK A/S.
As of June 30, 2025, Peter Esbjörn Rådqvist has left the board of directors of NOBEL BIOCARE DANMARK A/S.
As of June 30, 2025, Peter Esbjörn Rådqvist has stepped down as adm. dir. of NOBEL BIOCARE DANMARK A/S.
NOBEL BIOCARE DANMARK A/S has published its annual report for 2024. Gross profit came to DKK 3,772,945, and the net result was DKK -4,496,854.
As of May 28, 2025, Peter Esbjörn Rådqvist has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of May 28, 2025, Stefan Fabian Lieb has left the board of directors of NOBEL BIOCARE DANMARK A/S.
As of May 28, 2025, Peter Esbjörn Rådqvist is registered as adm. dir. of NOBEL BIOCARE DANMARK A/S.
As of May 28, 2025, Stefan Fabian Lieb has stepped down as adm. dir. of NOBEL BIOCARE DANMARK A/S.
About NOBEL BIOCARE DANMARK A/S
NOBEL BIOCARE DANMARK A/S is a Danish company of the type Aktieselskab based in Silkeborg, founded in 2004. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of Jan Jerne. The board consists of Magnus Karl Andreas Pettersson (chair), Harrieth Eva Elisabeth Sundaeus and Jan Jerne. The company is owned by Nobel Biocare AB. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 4,044,322 and a net result of DKK -4,810,707 compared with DKK -4,496,854 the year before. Equity in the 2025 report amounted to DKK -10,951,798.